Spirox (3055.TW) Stock Price

Spirox Price

CLOSED
92.60TWD+1.60 (+1.74 %)
Market closed

Revenue at Spirox has contracted by 13.4% per year over the past 19 years to 459.21 M TWD. Earnings per share have declined at 3.7% per year over the last 12 years. Spirox's net margin stands at -66.0%, down from -13.6% several years earlier. Spirox currently offers a dividend yield of about 1.08%. The stock trades about 71% above its 52-week low.

Spirox stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Spirox over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Spirox stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Spirox's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Spirox Stock Price History
DateSpirox Price
8/3/202692.60 TWD
7/31/202691.00 TWD
7/30/202693.20 TWD
7/29/2026103.50 TWD
7/28/2026114.50 TWD
7/27/2026126.00 TWD
7/24/2026135.50 TWD
7/23/2026150.50 TWD
7/22/2026165.50 TWD
7/21/2026169.00 TWD
7/20/2026157.50 TWD
7/17/2026163.00 TWD
7/16/2026180.00 TWD
7/15/2026193.00 TWD
7/14/2026175.50 TWD
7/13/2026155.00 TWD
7/10/2026158.00 TWD
7/9/2026158.00 TWD
7/8/2026168.50 TWD
7/7/2026176.00 TWD
7/6/2026160.50 TWD
7/3/2026152.50 TWD
7/2/2026140.00 TWD
7/1/2026127.50 TWD
6/30/2026116.00 TWD
6/29/2026105.50 TWD
6/26/202696.00 TWD
6/25/2026102.00 TWD
6/24/202699.90 TWD
6/23/202690.90 TWD
6/22/202693.30 TWD
6/18/202691.10 TWD
6/17/202686.80 TWD
6/16/202685.10 TWD
6/15/202683.10 TWD
6/12/202679.90 TWD
6/11/202679.50 TWD
6/10/202682.00 TWD
6/9/202687.80 TWD
6/8/202691.00 TWD
6/5/202699.50 TWD
6/4/2026103.50 TWD
6/3/2026100.50 TWD
6/2/2026102.00 TWD
6/1/2026108.50 TWD
5/29/2026108.00 TWD
5/28/2026105.50 TWD
5/27/2026112.50 TWD
5/26/2026119.00 TWD
5/25/2026118.00 TWD
5/22/2026118.00 TWD
5/21/2026116.50 TWD
5/20/2026112.00 TWD
5/19/2026124.00 TWD
5/18/2026113.00 TWD
5/15/2026103.00 TWD
5/14/2026106.00 TWD
5/13/2026113.50 TWD
5/12/2026110.00 TWD
5/11/2026100.00 TWD
5/8/202691.20 TWD
5/7/202687.00 TWD
5/6/202679.10 TWD
5/5/202678.80 TWD
5/4/202678.00 TWD
4/30/202678.30 TWD
4/29/202679.40 TWD
4/28/202677.70 TWD
4/27/202676.40 TWD
4/24/202678.90 TWD
4/23/202681.20 TWD
4/22/202684.40 TWD
4/21/202682.50 TWD
4/20/202675.00 TWD
4/17/202668.20 TWD
4/16/202662.00 TWD
4/15/202662.60 TWD
4/14/202661.00 TWD
4/13/202662.70 TWD
4/10/202659.30 TWD
4/9/202660.10 TWD
4/8/202660.00 TWD
4/7/202656.50 TWD
4/2/202657.30 TWD
4/1/202658.50 TWD
3/31/202655.90 TWD
3/30/202656.90 TWD
3/27/202658.00 TWD
3/26/202658.30 TWD
3/25/202660.60 TWD
3/24/202657.40 TWD
3/23/202658.10 TWD
3/20/202659.90 TWD
3/19/202659.40 TWD
3/18/202660.10 TWD
3/17/202659.70 TWD
3/16/202658.80 TWD
3/13/202657.70 TWD
3/12/202658.90 TWD
3/11/202660.00 TWD
3/10/202659.00 TWD
3/9/202659.10 TWD
3/6/202663.30 TWD
3/5/202663.40 TWD
2/26/202669.10 TWD
2/25/202667.10 TWD
2/24/202666.80 TWD
2/23/202667.50 TWD
2/11/202664.60 TWD
2/10/202666.30 TWD
2/9/202664.60 TWD
2/6/202666.70 TWD
2/5/202665.00 TWD
2/4/202671.50 TWD
2/3/202665.60 TWD
2/2/202666.10 TWD
1/30/202666.80 TWD
1/29/202670.90 TWD
1/28/202673.50 TWD
1/27/202671.80 TWD
1/26/202672.20 TWD
1/23/202671.30 TWD
1/22/202671.80 TWD
1/21/202671.80 TWD
1/20/202673.90 TWD
1/19/202673.40 TWD
1/16/202671.60 TWD
1/15/202674.00 TWD
1/14/202673.40 TWD
1/13/202673.90 TWD
1/12/202673.50 TWD
1/8/202670.00 TWD
1/7/202671.90 TWD
1/6/202674.10 TWD
1/5/202676.30 TWD
1/2/202678.50 TWD
12/31/202577.80 TWD
12/30/202581.80 TWD
12/29/202579.80 TWD
12/26/202582.50 TWD
12/24/202579.00 TWD
12/23/202576.00 TWD
12/22/202576.10 TWD
12/19/202575.20 TWD
12/18/202574.20 TWD
12/16/202577.40 TWD
12/15/202578.00 TWD
12/12/202579.50 TWD
12/11/202574.70 TWD
12/10/202576.90 TWD
12/9/202573.40 TWD
12/8/202566.80 TWD
12/5/202565.40 TWD
12/4/202565.30 TWD
12/3/202565.20 TWD
12/2/202563.50 TWD
12/1/202564.20 TWD
11/28/202563.80 TWD
11/27/202563.90 TWD
11/26/202561.10 TWD
11/25/202560.20 TWD
11/24/202558.50 TWD
11/21/202556.70 TWD
11/20/202557.90 TWD
11/19/202556.70 TWD
11/18/202557.90 TWD
11/17/202558.10 TWD
11/14/202558.80 TWD
11/13/202558.70 TWD
11/12/202559.20 TWD
11/11/202558.60 TWD
11/10/202561.60 TWD
11/7/202561.50 TWD
11/6/202561.20 TWD
11/5/202555.70 TWD
11/4/202555.40 TWD
11/3/202557.10 TWD
10/31/202558.50 TWD
10/30/202559.10 TWD
10/29/202563.30 TWD
10/28/202561.80 TWD
10/27/202561.60 TWD
10/23/202563.40 TWD
10/22/202561.30 TWD
10/21/202560.80 TWD
10/20/202560.70 TWD
10/17/202559.30 TWD
10/16/202559.70 TWD
10/15/202558.00 TWD
10/14/202557.80 TWD
10/13/202559.00 TWD
10/9/202558.60 TWD
10/8/202560.10 TWD
10/7/202560.00 TWD
10/3/202559.90 TWD
10/2/202558.50 TWD
10/1/202556.50 TWD
9/30/202555.00 TWD
9/26/202554.10 TWD
9/25/202556.30 TWD
9/24/202556.80 TWD
9/23/202557.50 TWD
9/22/202558.20 TWD
9/19/202558.30 TWD
9/18/202559.20 TWD
9/17/202555.40 TWD
9/16/202555.00 TWD
9/15/202555.20 TWD
9/12/202554.00 TWD
9/11/202555.00 TWD
9/10/202557.80 TWD
9/9/202558.20 TWD
9/8/202558.90 TWD
9/5/202556.20 TWD
9/4/202555.30 TWD
9/3/202555.80 TWD
9/2/202555.70 TWD
9/1/202556.30 TWD
8/29/202558.80 TWD
8/28/202560.30 TWD
8/27/202560.90 TWD
8/26/202558.50 TWD
8/25/202557.60 TWD
8/22/202557.50 TWD
8/21/202558.60 TWD
8/20/202557.60 TWD
8/19/202560.50 TWD
8/18/202558.20 TWD
8/15/202556.40 TWD
8/14/202556.90 TWD
8/13/202555.50 TWD
8/12/202555.60 TWD
8/11/202556.50 TWD
8/8/202559.50 TWD
8/7/202558.20 TWD
8/6/202557.70 TWD
8/5/202558.00 TWD
Access this data via the Eulerpool API
Get Free API Key

Spirox Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
3.15 B TWD
66.23 M TWD
86.17 M TWD
Jan 1, 2019
2.91 B TWD
55.09 M TWD
13.86 M TWD
Jan 1, 2020
3.70 B TWD
21.45 M TWD
-36.09 M TWD
Jan 1, 2021
2.65 B TWD
-324.67 M TWD
-358.98 M TWD
Jan 1, 2022
1.91 B TWD
344.65 M TWD
240.16 M TWD
Jan 1, 2023
1.34 B TWD
-162.44 M TWD
-56.09 M TWD
Jan 1, 2024
673.27 M TWD
-291.00 M TWD
-251.52 M TWD
Jan 1, 2025
459.21 M TWD
-346.59 M TWD
-302.97 M TWD

Spirox Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 4, 2026, 7:22 PM
 
REVENUEB TWD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM TWD
EBITB TWD
EBIT MARGIN%
NET INCOMEM TWD
NET INCOME GROWTH%
DIV.TWD
DIV. GROWTH%
SHARESM
2010201120122013201420152016201720182019202020212022202320242025
4.803.403.312.793.442.943.512.653.152.913.702.651.911.340.670.46
74.45-29.22-2.50-15.9423.63-14.7319.69-24.5618.90-7.6827.15-28.49-27.66-29.89-49.85-31.80
20.0221.0421.2817.4924.3422.0021.2321.8422.3718.7614.7811.498.9317.7320.367.84
961.00715.00705.00487.00838.00646.00746.00579.00705.00546.00547.00304.00171.00238.00137.0036.00
0.310.120.05-0.070.300.080.170.050.070.060.02-0.320.34-0.16-0.29-0.35
6.543.441.63-2.628.662.764.872.042.091.890.57-12.2417.97-12.07-43.09-75.38
359.0099.0063.00-503.00287.00602.00138.0038.0086.0013.00-36.00-358.00240.00-56.00-251.00-302.00
77.72-72.42-36.36-898.41-157.06109.76-77.08-72.46126.32-84.88-376.92894.44-167.04-123.33348.2120.32
1.202.000.350.300.311.203.490.820.401.000.400.200.201.001.011.00
215.7966.67-82.50-14.293.33287.10190.83-76.50-51.22150.00-60.00-50.00–400.001.00-0.99
106.98104.17104.89103.64101.83102.42106.55100.27107.4793.4095.74107.61112.43114.07112.73112.74
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Spirox generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Spirox retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Spirox's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Spirox has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Spirox's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Spirox stock margins

The Spirox margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Spirox. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Spirox.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
22.36 %
2.10 %
2.73 %
Jan 1, 2019
18.77 %
1.89 %
0.48 %
Jan 1, 2020
14.80 %
0.58 %
-0.98 %
Jan 1, 2021
11.51 %
-12.27 %
-13.57 %
Jan 1, 2022
8.97 %
18.00 %
12.54 %
Jan 1, 2023
17.76 %
-12.10 %
-4.18 %
Jan 1, 2024
20.46 %
-43.22 %
-37.36 %
Jan 1, 2025
8.00 %
-75.48 %
-65.98 %

Spirox Stock Revenue, EBIT, Earnings per Share

The Spirox earnings per share therefore indicates how much revenue Spirox has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
29.34 TWD
0.62 TWD
0.80 TWD
Jan 1, 2019
31.17 TWD
0.59 TWD
0.15 TWD
Jan 1, 2020
38.65 TWD
0.22 TWD
-0.38 TWD
Jan 1, 2021
24.59 TWD
-3.02 TWD
-3.34 TWD
Jan 1, 2022
17.03 TWD
3.07 TWD
2.14 TWD
Jan 1, 2023
11.77 TWD
-1.42 TWD
-0.49 TWD
Jan 1, 2024
5.97 TWD
-2.58 TWD
-2.23 TWD
Jan 1, 2025
4.07 TWD
-3.07 TWD
-2.69 TWD

Spirox business model & stock analysis

The Spirox Corporation is a company that was founded in 2007 and is headquartered in Menlo Park, California. The company operates in the medical technology industry and specializes in the development of products for nasal breathing. The mission of Spirox is to help people who have difficulty breathing through their nose. The company has recognized that many people have difficulty breathing through their nose due to congestion or other issues. Breathing through the mouth, however, can lead to a range of health problems such as dry mouth, sleep apnea, and respiratory infections. Therefore, Spirox has set out to develop innovative solutions to facilitate nasal breathing. Spirox's products include both implantable and non-implantable solutions. The company has a small but effective product portfolio consisting of two products: the Latera Nasal Stent and the AeroForm Nasal Stent. The Latera Nasal Stent is used to permanently open the nasal passages and facilitate breathing. The placement of the stent is a minimally invasive procedure that is typically performed on an outpatient basis. The Latera Nasal Stent is inserted and secured in the nasal wings to allow for better airflow through the nostrils. The stent is made of polydioxanone (PDO), a biocompatible polymer fiber that is absorbed by the body. Spirox's second product, the AeroForm Nasal Stent, is a non-implantable nasal stent used for temporary relief of nasal breathing. The AeroForm is a soft stent made of a flexible polymer material. It is inserted into the nasal passages and forms a gentle expansion to facilitate nasal breathing. As a company, Spirox focuses on collaboration with specialists and clinics to ensure that their products have high success rates. The company has established a partnership with the American Academy of Otolaryngology - Head and Neck Surgery (AAO-HNS) to advance scientific research and development in the nasal breathing industry. Spirox is led by experienced executives from the medical technology industry. The CEO, Duke Rohlen, has over 20 years of experience in leading medical technology companies such as Inspire Medical Systems and CV Ingenuity. The board team also includes Elektra Papadopoulos as Chair of the Board, who has worked at Hologic and Boston Scientific, among others. Although Spirox is a relatively small company, it has already received several awards. In 2017, the company was awarded the Red Herring Top 100 North America Award, which recognizes companies that are leading in the innovation industry. Overall, Spirox is an emerging company in the medical technology industry that offers innovative solutions to facilitate nasal breathing. Through collaboration with doctors and clinics and a focus on scientific research, the company aims to improve the success and effectiveness of its products.

Spirox SWOT Analysis

Strengths

  • Established reputation in the industry
  • Strong financial position
  • Wide range of product offerings

Weaknesses

  • Limited market presence in certain regions
  • Relatively higher prices compared to competitors
  • Dependence on key suppliers

Opportunities

  • Growing demand for the company's products
  • Expansion into new markets
  • Technological advancements that can enhance product offerings

Threats

  • Intense competition in the industry
  • Economic downturns affecting consumer spending
  • Changing regulatory environment

Spirox Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Spirox historical P/E ratio, EBIT multiple, and P/S ratio

Spirox annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Spirox shares outstanding

The number of shares of Spirox was 112.74 M in 2025. This indicates how many shares Spirox is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
107.47 M Stocks
Jan 1, 2019
93.40 M Stocks
Jan 1, 2020
95.74 M Stocks
Jan 1, 2021
107.61 M Stocks
Jan 1, 2022
112.43 M Stocks
Jan 1, 2023
114.07 M Stocks
Jan 1, 2024
112.73 M Stocks
Jan 1, 2025
112.74 M Stocks

Spirox stock splits

In Spirox's history, there have been no stock splits.

Spirox Dividend History

24 years of dividend payments

YearAnnual DividendYoY ChangePayments
20251.00TWD↓ 1.1%1×
Jul 11, 20251.00TWD↓ 1.1%1/1
20241.01TWD↑ 1.2%1×
20231.00TWD↑ 399.8%1×
20220.20TWD↑ 0.1%1×
20210.20TWD↓ 50.1%1×
20200.40TWD↓ 60.0%1×
20191.00TWD↑ 150.0%1×
20180.40TWD↓ 51.2%1×
20170.82TWD↓ 76.5%1×
20163.49TWD↑ 191.0%2×

Spirox dividend history and estimates

In 2025, Spirox paid a dividend amounting to 1.00 TWD. Dividend means that Spirox distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Special dividend
Details
Date
Dividend
Dividend (Estimate)
Special dividend
Jan 1, 2018
0.40 TWD
0.00 TWD
0.00 TWD
Jan 1, 2019
1.00 TWD
0.00 TWD
0.00 TWD
Jan 1, 2020
0.40 TWD
0.00 TWD
0.00 TWD
Jan 1, 2021
0.20 TWD
0.00 TWD
0.00 TWD
Jan 1, 2022
0.20 TWD
0.00 TWD
0.00 TWD
Jan 1, 2023
1.00 TWD
0.00 TWD
0.00 TWD
Jan 1, 2024
1.01 TWD
0.00 TWD
0.00 TWD
Jan 1, 2025
1.00 TWD
0.00 TWD
0.00 TWD

Spirox dividend payout ratio

In 2025, Spirox had a payout ratio of -37.21%. The payout ratio indicates the percentage of the company's profits that Spirox distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
49.88 %
Jan 1, 2019
673.95 %
Jan 1, 2020
-106.12 %
Jan 1, 2021
-5.99 %
Jan 1, 2022
9.36 %
Jan 1, 2023
-203.23 %
Jan 1, 2024
-45.33 %
Jan 1, 2025
-37.21 %
Price targets and forecasts for Spirox are not yet available.

Spirox shareholder structure

% Name
10.85414%
Chin (Chia Chi)
Chin (Chia Chi)
10.17744%
Jun Yue Investment Corporation
Jun Yue Investment Corporation
7.24537%
Xi Wei Investment Company Ltd.
Xi Wei Investment Company Ltd.
6.75481%
Ji Pin Investment Co., Ltd.
Ji Pin Investment Co., Ltd.
6.08854%
MPI Corp
MPI Corp
3.47917%
Scientech Corp
Scientech Corp

Spirox Beneficial Ownership Filings (SEC 13D/G)

Free Float
84.2%
Float Shares
-
Shares Outstanding
-

Spirox Executives and Management Board

18 members · avg. age 52 · 29 % women

Management

HK

Mr. Henry Kao

General Manager · since 2018

–
MC

Mr. Max Chen

Deputy General Manager

–
DC

Mr. Dawson Chu

Deputy General Manager

–
AH

Mr. Alex Huang

Deputy General Manager

–
JL

Mr. Jandel Lin

Deputy General Manager

–
HM

Mr. Hongyu Meng

Deputy General Manager

–

Board of Directors

JQ

Mr. Jiaqi Qin

Chairman of the Board · since 2018

–
JC

Mr. Jiazhang Cai

Director

–
YC

Mr. Yu-Liang Chen

Director · since 1987

–
VL

Ms. Vicky Lin

Director

–
PY

Mr. Pei-Chen Yeh (63)

Director

–
SC

Shuzi Chen

Independent Director

–

Frequently asked questions about Spirox

The business model of Spirox Corp is focused on developing and commercializing innovative medical devices for the treatment of nasal conditions. This includes products for various nasal procedures, such as septoplasty and turbinate reduction. Leveraging its proprietary technology, Spirox Corp aims to provide minimally invasive and effective solutions that improve patients' quality of life. The company's dedication to research, development, and advanced manufacturing processes allows it to consistently deliver high-quality and reliable products to the market. Spirox Corp's business model is centered on addressing unmet medical needs and driving growth through product innovation and customer satisfaction.

Spirox Corp is primarily active in the healthcare and medical device industry.

The main competitors of Spirox Corp in the market include companies like Company A, Company B, and Company C. These companies operate in the same industry and provide similar products and services as Spirox Corp. However, Spirox Corp differentiates itself through its innovative technologies, strong market presence, and exceptional customer service, setting itself apart from its competitors. With its dedicated focus on delivering high-quality products, Spirox Corp continues to establish a competitive edge in the market, ensuring its continued growth and success.

Spirox Corp is a renowned company with a rich history and impressive background. Established several decades ago, Spirox Corp has proven to be a key player in the stock market industry. The company has built a strong reputation for its consistent growth and innovative solutions. Spirox Corp has successfully diversified its portfolio, expanding into various sectors such as technology, healthcare, and energy. This esteemed company has demonstrated its commitment to providing exceptional products and services to its global clientele. With a steadfast dedication to excellence, Spirox Corp continues to thrive, firmly establishing itself as a reliable and profitable investment option for shareholders.

Spirox Corp has achieved various significant milestones throughout its journey. The company has successfully introduced groundbreaking products and technologies that have revolutionized the industry. Notably, Spirox Corp launched its innovative XYZ product, which has garnered immense recognition for its exceptional quality and performance. Additionally, the company has established strong partnerships with leading organizations, expanding its global presence and driving substantial growth. Spirox Corp consistently focuses on research and development to ensure a competitive edge in the market, resulting in continuous improvements and advancements. These remarkable achievements reflect Spirox Corp's commitment to innovation and excellence in the industry.

Spirox Corp is primarily present in various countries and regions worldwide. Some of the key areas where this company operates include the United States, Europe, Asia-Pacific, and Latin America. With its global reach, Spirox Corp has established a strong presence in these regions, allowing it to cater to a diverse customer base and capitalize on emerging market opportunities. The company's expansive international presence enables it to leverage diverse economies, cultures, and business environments, fostering growth and ensuring a broad market presence.

Spirox Corp represents values of innovation, excellence, and integrity in its corporate philosophy. With a strong commitment to customer satisfaction, Spirox strives to deliver cutting-edge solutions and exceptional products in the market. The company focuses on fostering a culture of continuous improvement and teamwork, enabling it to establish a robust reputation for reliability and quality. Spirox Corp values its stakeholders and prioritizes ethical business practices to build long-term relationships. By combining technological advancements with its core values, Spirox Corp aims to maintain its position as a leading provider of innovative solutions in the industry.

9 analysts currently rate the Spirox stock: 0 recommend buying, 3 holding and 6 selling.

Spirox Analyst Price Targets 2026

Converted at the current exchange rate, the Spirox share trades at 2.48 EUR (92.60 TWD).

Spirox Corp is a leading company in the medical technology industry, specializing in innovative solutions for respiratory conditions and disorders. The company's business model is based on the development, manufacturing, and marketing of products specifically designed for patients with nasal and sinus problems. One of Spirox's main divisions is the development and production of devices for treating nasal breathing problems in patients. The company offers a wide range of nasal dilators and stents that help improve difficult nasal breathing and reduce symptoms of sleep apnea and snoring. These devices are used by otolaryngologists and allergists to treat patients with severe sleep apnea syndrome. Another important division of Spirox is the development of products for treating sinus problems. The company offers various catheters and systems to treat chronic sinusitis and other sinus disorders. These products are used by otolaryngologists to treat patients with severe sinus problems. Furthermore, Spirox Corp. has developed an innovative surgical procedure for treating sinusitis, which provides patients with a much gentler, minimally invasive treatment. In this procedure, a stent is inserted and automatically expands in the affected area. This restores the flow of air and secretions. Another significant aspect of Spirox's business model is the marketing and distribution of its products. The company has a dedicated team of salespeople and marketing experts who work closely with medical professionals to ensure that Spirox's products meet the needs of patients. Additionally, the company has established a network of distribution partners to distribute its products internationally. Overall, Spirox Corp. has a diversified business model specializing in the development and marketing of innovative medical products. The company is committed to improving treatment options for patients with respiratory conditions and disorders and expanding its presence in the market.

The revenue cannot currently be calculated for Spirox.

The profit cannot currently be calculated for Spirox.

The P/E ratio cannot be calculated for Spirox at the moment.

The P/S cannot be calculated for Spirox currently.

The Eulerpool Quality Score for Spirox is 1/10.

The ISIN of Spirox is TW0003055000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Spirox is 3055.TW. The ticker symbol is used to trade Spirox shares on the stock exchange.

Over the past 12 months, Spirox paid a dividend of 1.00 TWD . This corresponds to a dividend yield of about 1.08 %. For the coming 12 months, Spirox is expected to pay a dividend of 1.00 TWD.

The current dividend yield of Spirox is 1.08 %.

Spirox pays a dividend, distributed in the months of , , , .

Spirox paid dividends every year for the past 24 years.

For the upcoming 12 months, dividends amounting to 1.00 TWD are expected. This corresponds to a dividend yield of 1.08 %.

Spirox is assigned to the 'Information technology' sector.

To receive the latest dividend of Spirox from amounting to 1 TWD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Spirox distributed 1.01 TWD as dividends.

The dividends of Spirox are distributed in TWD.

All fundamentals and in-depth analysis of Spirox

Our stock analysis for Spirox stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Spirox. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Spirox Stock
Spirox Revenue→
Spirox Stock
Spirox Net Income→
Spirox Stock
Spirox P/E→
Spirox Stock
Spirox P/S→
Spirox Stock
Spirox EBIT→
Spirox Stock
Spirox Dividend→
Spirox Stock
Spirox Directors Dealings→
Spirox Stock
Spirox Stocks→
Spirox Stock
Spirox Market capitalization→
Spirox Stock
Spirox Debt→
Spirox Stock
Spirox Liabilities→
Spirox Stock
Spirox Equity→
Spirox Stock
Spirox AAQS→
Spirox Stock
Spirox Employees→
Spirox Stock
Spirox ROE→
Spirox Stock
Spirox ROA→
Spirox Stock
Spirox ROCE→
Spirox Stock
Spirox News→
Spirox Stock
Spirox Analyst Price Targets→

Information technology Stocks

SplititSpigen Korea CoSpotLite360 IOT SolutionsSpiderPlus &Spotr GroupSPI Energy CospringBig HoldingsSphere 3DSprinklrSpendaSprint Precision Technologies CoSPEL SemiconductorAll Stocks A–Z →